Sidney Kimmel Comprehensive Cancer Center At Thomas Jefferson University
Clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center At Thomas Jefferson University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain zap study: will precision radiation save your memory? Results expected Sep 2026 (estimated)
- Could a constipation drug help fight colorectal cancer? Results expected Sep 2026 (estimated)
- Lung screening registry aims to uncover hidden COPD cases Results expected Dec 2026 (estimated)
- Can two existing drugs keep eye cancer from spreading? Results expected Dec 2026 (estimated)
- Can tai chi and acupuncture soothe chemo nerve damage? new study investigates Results expected Apr 2027 (estimated)
-
Common diabetes and acne drugs tested against cancer
Disease control Stopped earlyThis phase 2 trial tested whether combining metformin (a diabetes drug) with doxycycline (an antibiotic) could help treat localized breast and uterine cancers. The study enrolled 29 people who were scheduled for surgery. Researchers looked at changes in certain proteins in the tu…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising combo for prostate cancer halted early
Disease control Stopped earlyThis study looked at adding ribociclib to the standard hormone therapy enzalutamide for men with a certain type of advanced prostate cancer that had spread and no longer responded to hormone therapy alone. The goal was to find the best dose and see if the combination could lower …
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Lung cancer combo therapy trial stopped early
Disease control Stopped earlyThis study tested giving the immunotherapy drug nivolumab along with chemotherapy before surgery for people with early-stage non-small cell lung cancer (stages I to IIIA). The goal was to see if this combination could shrink tumors enough to leave less than 10% cancer cells in th…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Common diabetes and acne drugs studied for head and neck cancer treatment
Disease control Stopped earlyThis study tested whether metformin (a diabetes drug) and doxycycline (an antibiotic) could help treat head and neck cancer when taken before surgery. The trial aimed to see if these drugs could change certain proteins in the tumor's supportive tissue. Only 7 people took part bef…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Promising combo for eye cancer stalls after only 3 patients enrolled
Disease control Stopped earlyThis phase II trial tested a combination of precise radiation therapy followed by injections of aflibercept (Eylea) in people with uveal melanoma, a rare eye cancer. The goal was to see if this approach could control the tumor while reducing side effects like swelling or damage t…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Diabetes drug may ease thyroid treatment side effects
Symptom relief Stopped earlyThis small pilot study tested whether metformin, a common diabetes drug, could reduce side effects like dry mouth and taste changes from radioactive iodine treatment in people with thyroid cancer. Only 13 people took part, and the study was stopped early. The goal was to see if m…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC